These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
86 related items for PubMed ID: 17101593
1. Concurrent chemoradiotherapy with cyclophosphamide, pirarubicin, and cisplatin for patients with locally advanced salivary gland carcinoma. Katori H, Tsukuda M. Acta Otolaryngol; 2006 Dec; 126(12):1309-14. PubMed ID: 17101593 [Abstract] [Full Text] [Related]
2. Analysis of efficacy and toxicity of chemotherapy with cisplatin, 5-fluorouracil, methotrexate and leucovorin (PFML) and radiotherapy in the treatment of locally advanced squamous cell carcinoma of the head and neck. Katori H, Tsukuda M, Taguchi T. Cancer Chemother Pharmacol; 2007 May; 59(6):789-94. PubMed ID: 17053926 [Abstract] [Full Text] [Related]
3. Concurrent chemoradiotherapy for locally advanced and metastatic esophageal cancer: longterm results of a phase II study of UFT/CDDP with radiotherapy. Iwase H, Shimada M, Nakamura M, Nakarai K, Iyo T, Kaida S, Indo T, Kato E, Horiuchi Y, Kusugami K. Int J Clin Oncol; 2003 Oct; 8(5):305-11. PubMed ID: 14586756 [Abstract] [Full Text] [Related]
4. [Clinical effects of concurrent chemoradiotherapy (hyperfractionation and cisplatin/5-fluorouracil) for patients with advanced oral squamous cell carcinoma]. Tsuchiya Y, Noguchi T, Matsumoto K, Matsumura T, Hoshi K, Ito H, Osano H, Jinbu Y, Kusama M. Gan To Kagaku Ryoho; 2009 Jan; 36(1):101-3. PubMed ID: 19151572 [Abstract] [Full Text] [Related]
5. A feasibility study of topotecan with standard-dose cisplatin and concurrent primary radiation therapy in locally advanced cervical cancer. Gatcliffe TA, Tewari KS, Shah A, Brewster WR, Burger RA, Kuo JV, Monk BJ. Gynecol Oncol; 2009 Jan; 112(1):85-9. PubMed ID: 18977518 [Abstract] [Full Text] [Related]
6. Concurrent chemoradiotherapy with pirarubicin and 5-fluorouracil for resectable oral and maxillary carcinoma. Iguchi H, Kusuki M, Nakamura A, Nishiura H, Kanazawa A, Takayama M, Sunami K, Yamane H. Acta Otolaryngol Suppl; 2004 Oct; (554):55-61. PubMed ID: 15513513 [Abstract] [Full Text] [Related]
7. Effectiveness of pharmacokinetic modulating chemotherapy combined with cisplatin as induction chemotherapy in resectable locally advanced head and neck cancer: phase II study. Chang PM, Chen PM, Chu PY, Wang LW, Tai SK, Tsai TL, Huang JL, Wang YF, Chang SY, Yang MH. Cancer Chemother Pharmacol; 2008 Dec; 63(1):9-17. PubMed ID: 18343925 [Abstract] [Full Text] [Related]
8. [Preoperative concurrent chemoradiotherapy with intra-arterial infusion of pirarubicin and continuous intravenous instillation of 5-fluorouracil for resectable advanced head and neck squamous cell carcinoma]. Iguchi H, Kusuki M, Nakamura A, Nishiura H, Kanazawa A, Yamane H. Gan To Kagaku Ryoho; 2003 Mar; 30(3):391-7. PubMed ID: 12669399 [Abstract] [Full Text] [Related]
18. Induction chemotherapy with S-1 plus cisplatin in patients with locally advanced squamous cell carcinoma of the head and neck. Choi YJ, Chung JS, Shin HJ, Cho GJ, Wang SG, Lee BJ, Cho BM, Joo YD, Sohn CH. J Laryngol Otol; 2008 Aug 20; 122(8):848-53. PubMed ID: 18047761 [Abstract] [Full Text] [Related]
19. Induction chemotherapy followed by alternating chemo-radiotherapy in non-endemic undifferentiated carcinoma of the nasopharynx: optimal compliance and promising 4-year results. Ponzanelli A, Vigo V, Marcenaro M, Bacigalupo A, Gatteschi B, Ravetti JL, Corvò R, Benasso M. Oral Oncol; 2008 Aug 20; 44(8):767-74. PubMed ID: 18061519 [Abstract] [Full Text] [Related]
20. Therapy of stage IV B anaplastic thyroid carcinoma: single institution experience. Vrbic S, Pejcic I, Vrbic M, Filipovic S. J BUON; 2009 Aug 20; 14(1):41-4. PubMed ID: 19373945 [Abstract] [Full Text] [Related] Page: [Next] [New Search]